Last reviewed · How we verify

NCT03126162

Postoperative Bladder Testing After Total Laparoscopic Hysterectomy

Completed NA Last updated 6 June 2018
What this trial tests

NA trial testing InstilIing normal saline into bladder in Laparoscopic Hysterectomy in 172 participants. Completed in 4 May 2018.

Timeline
8 June 2017
Primary endpoint
4 May 2018
4 May 2018

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment172
Start date8 June 2017
Primary completion4 May 2018
Estimated completion4 May 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Adults 18 to 75, female only, with Laparoscopic Hysterectomy or Enhanced Recovery After Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to determine if backfilling the bladder immediately post-operatively, prior to removal of the foley catheter, in patients undergoing same-day total laparoscopic hysterectomy will hasten time to first spontaneous void and time to discharge

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge: A Randomized Controlled Trial.
    Chao L, Mansuria S. · · 2019 · cited 16× · PMID 30969209 · DOI 10.1097/aog.0000000000003191

Verify or expand the search:

Other recruiting trials for Laparoscopic Hysterectomy

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03126162.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing